Transaction in Own Shares

Summary by AI BETAClose X

On October 6, 2025, GSK plc, acting through BNP Paribas SA, purchased 340,000 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought at prices ranging from 1,594.00p to 1,624.50p per share, with a volume-weighted average price of 1,614.05p. These shares will be held as treasury shares as part of an existing buyback program announced on September 30, 2025; since then, GSK has purchased 1,592,000 ordinary shares. Following this transaction, GSK will hold 249,056,844 ordinary shares in treasury, representing 6.12 percent of the voting rights, and have 4,066,351,695 ordinary shares in issue, excluding treasury shares. The total number of voting rights in the company is 4,066,351,695.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings